Emapalumab for the Treatment of Peri-Graft Hemophagocytic Lymphohistiocytosis Reactivation in a Patient With Familial Hemophagocytic Lymphohistiocytosis Type 3.
- DOI
- 10.1002/1545-5017.70480
- Published
- 2026 Sep
- Container
- Pediatric blood & cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/1545-5017.70480,
title = {Emapalumab for the Treatment of Peri-Graft Hemophagocytic Lymphohistiocytosis Reactivation in a Patient With Familial Hemophagocytic Lymphohistiocytosis Type 3.},
author = {Plaza Fornieles M and Bermúdez Cortés M and Martínez Sánchez MV and Tovar Pérez M and Jiménez I and Galera Miñarro A and Llinares Riestra ME and Fuster Soler JL and Blanquer Blanquer M and García Hernández AM and González Ponce CM and Gómez Imbernón E and Salgado-Cecilia G and Montes-Ares O and Sánchez Salinas A},
year = {2026},
journal = {Pediatric blood \& cancer},
doi = {10.1002/1545-5017.70480},
url = {https://doi.org/10.1002/1545-5017.70480}
}RIS
TY - JOUR TI - Emapalumab for the Treatment of Peri-Graft Hemophagocytic Lymphohistiocytosis Reactivation in a Patient With Familial Hemophagocytic Lymphohistiocytosis Type 3. AU - Plaza Fornieles M AU - Bermúdez Cortés M AU - Martínez Sánchez MV AU - Tovar Pérez M AU - Jiménez I AU - Galera Miñarro A AU - Llinares Riestra ME AU - Fuster Soler JL AU - Blanquer Blanquer M AU - García Hernández AM AU - González Ponce CM AU - Gómez Imbernón E AU - Salgado-Cecilia G AU - Montes-Ares O AU - Sánchez Salinas A PY - 2026 JO - Pediatric blood & cancer DO - 10.1002/1545-5017.70480 UR - https://doi.org/10.1002/1545-5017.70480 ER -
APA
M, P. F., M, B. C., MV, M. S., M, T. P., I, J., A, G. M., ME, L. R., JL, F. S., M, B. B., AM, G. H., CM, G. P., E, G. I., G, S., O, M., & A, S. S. (2026). Emapalumab for the Treatment of Peri-Graft Hemophagocytic Lymphohistiocytosis Reactivation in a Patient With Familial Hemophagocytic Lymphohistiocytosis Type 3.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70480
Source records
- pubmed · retrieved 2026-09-27T09:08:40.723Z